Ghia P

Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study.

Visentin A, Gaffo E, Fürstenau M, ..., Trentin L, Bortoluzzi S

Leukemia 39 (12) 2957-2967 [2025-12-00; online 2025-09-19]

Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms.

Nadeu F, Shuai S, Clot G, ..., Puente XS, Campo E

Leukemia 39 (9) 2076-2086 [2025-09-00; online 2025-06-30]

The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia.

Hägerstrand D, Oder B, Cortese D, ..., Sutton LA, Rosenquist R

Leukemia 38 (11) 2429-2442 [2024-11-00; online 2024-09-11]

The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.

Visentin A, Chatzikonstantinou T, Scarfò L, ..., Stamatopoulos K, Ghia P

Am. J. Hematol. 98 (12) 1856-1868 [2023-12-00; online 2023-09-29]

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib.

Bonfiglio S, Sutton LA, Ljungström V, ..., Rosenquist R, Ghia P

Blood Adv 7 (12) 2794-2806 [2023-06-27; online 2023-01-26]

Secondary resistance to idelalisib is characterized by upregulation of IGF1R rather than by MAPK/ERK pathway mutations.

Tausch E, Ljungström V, Agathangelidis A, ..., Rosenquist R, Stilgenbauer S

Blood 139 (22) 3340-3344 [2022-06-02; online 2022-04-05]

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.

Chatzikonstantinou T, Kapetanakis A, Scarfò L, ..., Stamatopoulos K, Ghia P

Leukemia 35 (12) 3444-3454 [2021-12-00; online 2021-11-01]

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation.

Malcikova J, Tausch E, Rossi D, ..., Pospisilova S, European Research Initiative on Chronic Lymphocytic Leukemia (ERIC) — TP53 network

Leukemia 32 (5) 1070-1080 [2018-05-00; online 2018-02-02]

EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia.

Young E, Noerenberg D, Mansouri L, ..., Rosenquist R, Damm F

Leukemia 31 (7) 1547-1554 [2017-07-00; online 2016-11-28]

Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations.

Rosenquist R, Ghia P, Hadzidimitriou A, ..., Davi F, Stamatopoulos K

Leukemia 31 (7) 1477-1481 [2017-07-00; online 2017-04-25]

B Cell Anergy Modulated by TLR1/2 and the miR-17∼92 Cluster Underlies the Indolent Clinical Course of Chronic Lymphocytic Leukemia Stereotyped Subset #4.

Ntoufa S, Papakonstantinou N, Apollonio B, ..., Ghia P, Stamatopoulos K

J. Immunol. 196 (10) 4410-4417 [2016-05-15; online 2016-04-08]